Literature DB >> 29914959

Mutations in gyrA and gyrB in Moxifloxacin-Resistant Mycobacterium avium Complex and Mycobacterium abscessus Complex Clinical Isolates.

Su-Young Kim1, Byung Woo Jhun1, Seong Mi Moon1, Sun Hye Shin1, Kyeongman Jeon1, O Jung Kwon1, In Young Yoo2, Hee Jae Huh2, Chang-Seok Ki2, Nam Yong Lee2, Sung Jae Shin3, Charles L Daley4, Gee Young Suh5, Won-Jung Koh5.   

Abstract

Data on the frequency of gyrA and gyrB mutations in fluoroquinolone-resistant isolates of the Mycobacterium avium complex (MAC) and the Mycobacterium abscessus complex (MABC) are limited. In our analysis, we did not find any resistance-associated mutations in gyrA or gyrB in 105 MAC or MABC clinical isolates, including 72 moxifloxacin-resistant isolates. Our findings suggest that mechanisms other than gyrA and gyrB mutations contribute to moxifloxacin resistance in these organisms.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Mycobacterium abscessus complex; Mycobacterium avium complex; gyrase mutation; moxifloxacin; resistance

Mesh：

Substances：

Year:  2018        PMID： 29914959      PMCID： PMC6125518          DOI： 10.1128/AAC.00527-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  36 in total

1.  Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes.

Authors:  Jean-Noël Dauendorffer; Isabelle Guillemin; Alexandra Aubry; Chantal Truffot-Pernot; Wladimir Sougakoff; Vincent Jarlier; Emmanuelle Cambau
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.

Authors:  Zofia Bakuła; Magdalena Modrzejewska; Lian Pennings; Małgorzata Proboszcz; Aleksandra Safianowska; Jacek Bielecki; Jakko van Ingen; Tomasz Jagielski
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

3.  High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.

Authors:  Rose Devasia; Amondrea Blackman; Svetlana Eden; Haijing Li; Fernanda Maruri; Ayumi Shintani; Charles Alexander; Anne Kaiga; Charles W Stratton; Jon Warkentin; Yi-Wei Tang; Timothy R Sterling
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

4.  Subspecies distribution and macrolide and fluoroquinolone resistance genetics of Mycobacterium abscessus in Korea.

Authors:  J Kim; H Sung; J-S Park; S-H Choi; T-S Shim; M-N Kim
Journal:  Int J Tuberc Lung Dis       Date:  2016-01       Impact factor: 2.373

5.  The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Authors:  Wouter Hoefsloot; Jakko van Ingen; Claire Andrejak; Kristian Angeby; Rosine Bauriaud; Pascale Bemer; Natalie Beylis; Martin J Boeree; Juana Cacho; Violet Chihota; Erica Chimara; Gavin Churchyard; Raquel Cias; Rosa Daza; Charles L Daley; P N Richard Dekhuijzen; Diego Domingo; Francis Drobniewski; Jaime Esteban; Maryse Fauville-Dufaux; Dorte Bek Folkvardsen; Noel Gibbons; Enrique Gómez-Mampaso; Rosa Gonzalez; Harald Hoffmann; Po-Ren Hsueh; Alexander Indra; Tomasz Jagielski; Frances Jamieson; Mateja Jankovic; Eefje Jong; Joseph Keane; Wo-Jung Koh; Berit Lange; Sylvia Leao; Rita Macedo; Turid Mannsåker; Theodore K Marras; Jeannette Maugein; Heather J Milburn; Tamas Mlinkó; Nora Morcillo; Kozo Morimoto; Dimitrios Papaventsis; Elia Palenque; Mar Paez-Peña; Claudio Piersimoni; Monika Polanová; Nalin Rastogi; Elvira Richter; Maria Jesus Ruiz-Serrano; Anabela Silva; M Pedro da Silva; Hulya Simsek; Dick van Soolingen; Nora Szabó; Rachel Thomson; Teresa Tórtola Fernandez; Enrico Tortoli; Sarah E Totten; Greg Tyrrell; Tuula Vasankari; Miguel Villar; Renata Walkiewicz; Kevin L Winthrop; Dirk Wagner
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

6.  Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones.

Authors:  I Guillemin; E Cambau; V Jarlier
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

7.  A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis.

Authors:  Brandon Eilertson; Fernanda Maruri; Amondrea Blackman; Yan Guo; Miguel Herrera; Yuri van der Heijden; Yu Shyr; Timothy R Sterling
Journal:  J Antimicrob Chemother       Date:  2016-06-03       Impact factor: 5.790

8.  Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.

Authors:  Jotam G Pasipanodya; Deborah Ogbonna; Beatriz E Ferro; Gesham Magombedze; Shashikant Srivastava; Devyani Deshpande; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

9.  The drug resistance profile of Mycobacterium abscessus group strains from Korea.

Authors:  Seung Heon Lee; Hee Kyung Yoo; Seol Hee Kim; Won-Jung Koh; Chang Ki Kim; Young Kil Park; Hee Jin Kim
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

10.  Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.

Authors:  Su-Young Kim; Sung Jae Shin; Byeong-Ho Jeong; Won-Jung Koh
Journal:  BMC Infect Dis       Date:  2016-05-17       Impact factor: 3.090
View more
  5 in total

1.  Epidemiology, Environmental Risks, Virulence, and Resistance Determinants of Klebsiella pneumoniae From Dairy Cows in Hubei, China.

Authors:  Xiangyun Wu; Jiayi Liu; Jiawei Feng; Muhammad Abu Bakr Shabbir; Yali Feng; Rui Guo; Meifang Zhou; Sulin Hou; Guiqiang Wang; Haihong Hao; Guyue Cheng; Yulian Wang
Journal:  Front Microbiol       Date:  2022-05-04       Impact factor: 6.064

Review 2.  Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients.

Authors:  Giulia Degiacomi; José Camilla Sammartino; Laurent Roberto Chiarelli; Olga Riabova; Vadim Makarov; Maria Rosalia Pasca
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

Review 3.  Nontuberculous Mycobacterial Resistance to Antibiotics and Disinfectants: Challenges Still Ahead.

Authors:  Samira Tarashi; Seyed Davar Siadat; Abolfazl Fateh
Journal:  Biomed Res Int       Date:  2022-02-26       Impact factor: 3.411

4.  Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus.

Authors:  Abdeldjalil Madani; Dereje A Negatu; Abdellatif El Marrouni; Randy R Miller; Christopher W Boyce; Nicholas Murgolo; Christopher J Bungard; Matthew D Zimmerman; Véronique Dartois; Martin Gengenbacher; David B Olsen; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2022-08-25       Impact factor: 5.938

5.  A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.

Authors:  Uday S Ganapathy; Rubén González Del Río; Mónica Cacho-Izquierdo; Fátima Ortega; Joël Lelièvre; David Barros-Aguirre; Wassihun Wedajo Aragaw; Matthew D Zimmerman; Marissa Lindman; Véronique Dartois; Martin Gengenbacher; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2021-10-04       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.